Exactly. The "disease modification" is about dialing down hypersensitization to pain. It doesn't touch the underlying pathology. Hard to justify the DMOAD claim.
Great to have more and better pain management options though. Good luck to them.
- Forums
- ASX - By Stock
- No. of patients treated so far
Exactly. The "disease modification" is about dialing down...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M |
Open | High | Low | Value | Volume |
23.0¢ | 23.0¢ | 21.5¢ | $78.13K | 350.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 64880 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 43479 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 64880 | 0.220 |
12 | 212910 | 0.215 |
14 | 245866 | 0.210 |
8 | 182478 | 0.205 |
30 | 784855 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 43479 | 1 |
0.230 | 84999 | 2 |
0.235 | 26540 | 1 |
0.240 | 103500 | 4 |
0.250 | 109857 | 5 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online